Originally Posted by UK_
They'll be presenting Phase 2 results at a conference on 9 - 12 May.
But everyone will still be talking about 3% rubbish Replicel.
Wow so we will know more about Histogen within a week, exciting!!
People need to put Replicel's results to the back of their mind and let them crack on with it. Granted 3% is not a very good result, but its early days yet and other than the results being underwhelming there was no safety concerns or problems....Anyway I don't want this to turn into another rant about replicel's results.
Will this be the end of Phase 2 for Histogen, or more still to test? Will they be announcing safety, effectiveness, viability at this conference??